Article
Potent Stimulation of the Androgen Receptor Instigates a Viral Mimicry Response in Prostate Cancer
6 Jul 2022
Abstract excerpt
Inhibiting the androgen receptor (AR), a ligand-activated transcription factor, with androgen deprivation therapy is a standard-of-care treatment for metastatic prostate cancer. Paradoxically, activation of AR can also inhibit the growth of prostate cancer in some patients and experimental systems, but the mechanisms underlying this phenomenon are poorly understood. This study exploited a potent synthetic...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
